News|Articles|November 4, 2025

Supporting blood sugar and GLP-1 secretion with citrus flavonoids

Key Takeaways

  • Eriomin supports blood sugar and metabolic health by promoting GLP-1 secretion, with sustained effects over 12 weeks.
  • Unlike synthetic GLP-1 agonists, Eriomin naturally enhances the body's GLP-1 production without adverse effects.
SHOW MORE

Nutritional Outlook interviews Doug Lynch of Ingredients by Nature about the blood sugar benefits of its citrus flavonoid ingredient Eriomin.

Sebastian Krawiec: So, Ingredients by Nature’s Eriomin citrus flavonoid Ingredient has been shown to support blood sugar and metabolic health via GLP-1 secretion. It's my understanding that there's new research on that ingredient. So would you be able to tell us a little bit about that new research, its design, and what the results have shown? Right?

Doug Lynch: We're very, very proud of our research. We actually have three published studies prior to the fourth now that just came out. Each of these have shown a dramatic impact on GLP-1 boosting. And yes, you're right, glucose was one of the main pathways that we were looking at, as well as inflammatory benefits that you can actually receive from the ingredient as well. And that's really important, because it's not enough to just say you're boosting GLP-1. I would dare say there's 70% of companies talking about GLP-1. That's the only thing they can say. They put everybody on the same exact diet, and then, and then they basically give them something that spikes their GLP-1 levels. Well, GLP-1 actually goes out of your system as fast as you create it. What's amazing about the Eriomin ingredient is that we actually have long-term studies that have actually shown building up against baseline for 12 weeks, that we're actually having a sustained impact with GLP-1. And where that matters is, what are the markers that are getting benefits from it? So back to the glucose pathways that we're managing healthy blood sugar levels. That's the evidence that the efficacy is actually working.

It's not enough to just say, Oh, those numbers went up. Yeah, that's how the body works. But in our case, those numbers going up are actually having a benefit to your to your glucose levels.There are a lot of consumers that are on drugs for GLP-1 boosting, at some point they have to get off. And so if there's a way that they can have sort of [provide] a soft landing, because what happens is, if you're on an injectable product, you lose your weight, and you lose your fat, but you also lose muscle. And the challenge here is that when you come off these drugs, the fat comes back. So, there has to be an alternative to those for people that want to have a soft landing when they come off those medications, and those that are taking the medications proactively for diabetes.

For example, Metformin is a very inexpensive ingredient or pharmaceutical active. And so people are actually taking it proactively. When doctors say that they're technically, they're not diabetic yet, but they're showing metabolic distress. So, a number of doctors will put people on Metformin just to see if there's a benefit. That's exactly the type of people that we actually did our study for to show that that you're not going to have an adverse reaction on Eriomin’s effectiveness, and you're not going to have an adverse reaction on the Metformin. So we have an issued patent on GLP-1 boosting, we have now four human studies. Really, it's unparalleled research in GLP-1

SK: Specifically, was there any benefit to taking area men with the Metformin?

DL: What we indicated is that in the group that just took Metformin alone, there were impacts adverse to the GLP-1, and then we showed that that impact did not= manifest itself when in the combination with Eriomin.

SK: So obviously, GLP-1 has grown to be a huge trend. You know, some brands focusing on supporting GLP-1 drug users through various pathways, usually with regard to side effects, right? You guys are taking a different path with regard to secretion of the GLP-1 hormone. From your perspective, what is the role of the nutraceutical industry as it relates to GLP-1 hormones and all the innovation that we're seeing here. Because in some ways, it's a little bit of a slippery slope, sometimes how people are talking about this relationship,

DL:

There are groups of people that are very much concerned about the side effects of the GLP-1 drug, so they never start them, even though there's tremendous data. I mean, that goes back decades. These things just didn't get invented in the last month or two. Sure, the research and the pharmaceutical benefits of this have been going back for decades, but they're very costly too. They're fairly expensive. So, a number of people don't like the side effects and they're concerned about them. Some don't like the expense. So, there's a group of people that will always want to find a natural alternative to a drug. Now, in a drugs case, they don't create GLP-1. It's a GLP-1 agonist. In other words, it looks like GLP-1, and it kind of floods the zone with the GLP-1, and that has the dramatic impact which people see in very, very rapid weight loss. But unfortunately, that also leads to other problems down the road as well. In our case, we're not taking a fake GLP-1 and giving it to the body. We are basically promoting the body's ability to do what it normally does, which is to make GLP-1 in the first place. So it's a more natural approach to it. We've, we've had 10s of 1000s, if not hundreds of 1000s of doses that have been taken with Eriomin. We have no complaints, we have no concerns of safety that have ever come our way, and to be sure, that just shows that this is your body doing what it is meant to do a natural boosting of GLP-1.

Newsletter

From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.